Skip to main content
. Author manuscript; available in PMC: 2014 Sep 6.
Published in final edited form as: J Clin Psychiatry. 2012 May 15;73(6):843–848. doi: 10.4088/JCP.11m07139

Table 2.

Univariate ANOVA Examining Impact of Baseline Levels of One-Carbon Cycle Intermediates on Post-Treatment Levels

Intermediate df F p Power
SAMe post
Treatment 1 0.06 0.81 0.06
SAMe Pre 1 0.47 0.5 0.1
Treatment X SAMe pre 1 0.58 0.45 0.11
SAH post
Treatment 1 0.57 0.46 0.11
SAH Pre 1 0.8 0.38 0.13
Treatment X SAH pre 1 0.13 0.72 0.06
tHCY post
Treatment 1 1.58 0.22 0.22
tHCY Pre 1 25.39 <0.0001 1
Treatment X tHCY pre 1 2.75 0.11 0.35
MET post
Treatment 1 1.09 0.3 0.17
MET Pre 1 8.11 0.008 0.8
Treatment X MET pre 1 1.07 0.31 0.16
5-MTHF post
Treatment 1 5.03 0.03 0.58
5-MTHF Pre 1 7.29 0.01 0.75
Treatment X 5-MTHF pre 1 5.7 0.02 0.64